309 related articles for article (PubMed ID: 24237244)
1. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
[TBL] [Abstract][Full Text] [Related]
2. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
Amrein K; Amrein S; Drexler C; Dimai HP; Dobnig H; Pfeifer K; Tomaschitz A; Pieber TR; Fahrleitner-Pammer A
J Clin Endocrinol Metab; 2012 Jan; 97(1):148-54. PubMed ID: 21994959
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus.
Catalano A; Pintaudi B; Morabito N; Di Vieste G; Giunta L; Bruno ML; Cucinotta D; Lasco A; Di Benedetto A
Eur J Endocrinol; 2014 Sep; 171(3):293-300. PubMed ID: 24891138
[TBL] [Abstract][Full Text] [Related]
6. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
7. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
Yamamoto M; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
[TBL] [Abstract][Full Text] [Related]
8. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
[TBL] [Abstract][Full Text] [Related]
9. Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
Kocijan R; Muschitz C; Fahrleitner-Pammer A; Amrein K; Pietschmann P; Haschka J; Dinu S; Kapiotis S; Resch H
J Clin Endocrinol Metab; 2014 Feb; 99(2):E311-9. PubMed ID: 24203063
[TBL] [Abstract][Full Text] [Related]
10. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.
Szulc P; Bertholon C; Borel O; Marchand F; Chapurlat R
J Bone Miner Res; 2013 Apr; 28(4):855-64. PubMed ID: 23165952
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
12. Physical activity in relation to serum sclerostin, insulin-like growth factor-1, and bone turnover markers in healthy premenopausal women: a cross-sectional and a longitudinal study.
Ardawi MS; Rouzi AA; Qari MH
J Clin Endocrinol Metab; 2012 Oct; 97(10):3691-9. PubMed ID: 22865898
[TBL] [Abstract][Full Text] [Related]
13. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
[TBL] [Abstract][Full Text] [Related]
14. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE
J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318
[TBL] [Abstract][Full Text] [Related]
15. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
[TBL] [Abstract][Full Text] [Related]
17. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
Zhou YJ; Li A; Song YL; Zhou H; Li Y; Tang YS
Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
[TBL] [Abstract][Full Text] [Related]
18. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
[TBL] [Abstract][Full Text] [Related]
19. Serum sclerostin in alcoholics: a pilot study.
González-Reimers E; Martín-González C; de la Vega-Prieto MJ; Pelazas-González R; Fernández-Rodríguez C; López-Prieto J; Alvisa-Negrín J; Santolaria-Fernández F
Alcohol Alcohol; 2013; 48(3):278-82. PubMed ID: 23296214
[TBL] [Abstract][Full Text] [Related]
20. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
